After a very profitable decade on Microsoft’s board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus. Read more: Read More
Blogs and news from the borders of America.
After a very profitable decade on Microsoft’s board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus. Read more: Read More